Cyclo Therapeutics Inc. completed its name change after receiving necessary approvals from its shareholders and relevant regulators.
The Alachua, Fla.-based biotechnology, which develops cyclodextrin-based drugs, previously operated as CTD Holdings Inc.
The company's shares will continue trading on the OTCQB exchange under the ticker symbol CTDH, Cyclo Therapeutics noted in its Oct. 4 news release.
